FINNENCE ▪ THE WIRE FILE
THE WIRE · № 77075
News▲ Bullish
Rona Therapeutics enters into global license agreement with Roche for ALK7-targeting RNAi therapy for obesity and metabolic diseases
KINDNews
DIRECTION▲ Bullish
SOURCES1
ENTITIES3
STORY SIZESTANDALONE
FIRST SEEN
LAST UPDATE
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
Roche licensing an ALK7 RNAi obesity candidate signals continued pharma appetite for metabolic assets.
Obesity pipeline deal signals sustained pharma demand
CATALYST TO WATCH
Clinical progress of ALK7 RNAi candidate
MAIN RISK
Early-stage candidate may fail trials
FULL DISPATCH
SANTA BARBARA, Calif., Oct. 13, 2026 /PRNewswire/ -- Rona Therapeutics today announced it has granted Roche (SIX: RO, ROG; OTCQX: RHHBY) an exclusive worldwide license for Rona's investigational RNAi candidate targeting activin receptor-like kinase 7 (ALK7) utilizing the company's...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
←CORRELATIONshares Healthcare, LLY
Gottlieb on how AI is assisting in the development of cancer vaccines2026-10-12 19:00 UTC
Gottlieb on how AI is assisting in the development of cancer vaccines2026-10-12 19:00 UTC
←CORRELATIONshares Healthcare
Why This IPO Stock, An AnaptysBio Spinoff, Just Surged2026-10-12 20:10 UTC
Why This IPO Stock, An AnaptysBio Spinoff, Just Surged2026-10-12 20:10 UTC
←CORRELATIONshares Healthcare
ACG 2026 Data Show TissueCypher® Identifies Elevated Risk of Progression Beyond Pathology Findings in Barrett's Esophagus2026-10-12 20:30 UTC
ACG 2026 Data Show TissueCypher® Identifies Elevated Risk of Progression Beyond Pathology Findings in Barrett's Esophagus2026-10-12 20:30 UTC
←CORRELATIONshares Healthcare
Corcept Seeks to Block Ex-Judge’s Testimony in Teva Antitrust Fight2026-10-12 20:58 UTC
Corcept Seeks to Block Ex-Judge’s Testimony in Teva Antitrust Fight2026-10-12 20:58 UTC
←CORRELATIONshares Healthcare
Breakthrough T1D Concludes Inaugural Clinical & Research Congress, Highlighting Global Advances in Type 1 Diabetes Research2026-10-12 21:55 UTC
Breakthrough T1D Concludes Inaugural Clinical & Research Congress, Highlighting Global Advances in Type 1 Diabetes Research2026-10-12 21:55 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.